Kordonouri O, Hartmann R, Deiss D, Wilms M, Grüters-Kieslich A
Clinic of General Pediatrics, Otto-Heubner-Centrum, Charité, Campus Virchow-Klinikum, Humboldt University, Berlin, Germany.
Arch Dis Child. 2005 Apr;90(4):411-4. doi: 10.1136/adc.2004.056424.
To investigate the natural history and incidence of autoimmune thyroiditis (AIT) in paediatric patients with type 1 diabetes (T1D).
Since 1990, annual screening for thyroid disease has been performed in children and adolescents with T1D. Antibodies against thyroperoxidase (anti-TPO) and thyroglobulin (anti-TG) as well as TSH were measured in 659 patients (54.3% boys). In 126 patients, anti-TPO and anti-TG levels were followed at yearly intervals from onset up to five years of T1D. Anti-TPO above 30 U/ml and anti-TG above 20 U/ml were considered positive, values above 100 U/ml as significantly raised and indicative of AIT. L-thyroxine treatment was started if TSH was higher than 4.5 microU/ml and/or thyroid gland enlargement on thyroid ultrasound was present.
At initial screening, 15.4% of patients had raised anti-TPO and 14.4% anti-TG. Girls had more frequently raised antibodies than boys. Sixty two patients (9.4%, 61% girls) required treatment with L-thyroxine. The cumulative incidence (SE) of AIT after 10 years of diabetes was 0.14 (0.02), being significantly higher in females (0.18 (0.03)), particularly after the age of 12 years. At T1D onset, positive anti-TPO and anti-TG were present in 21 of 126 patients (16.7%), each. All patients with significantly increased values of anti-TPO (n = 17, 148-5340 U/ml) and anti-TG (n = 11, 140-2000 U/ml) at T1D onset remained positive during the following five years.
For early detection of autoimmune thyroiditis in children with T1D, measurement of anti-TPO and TSH at T1D onset and in yearly intervals after the age of 12 years is recommended.
研究1型糖尿病(T1D)患儿自身免疫性甲状腺炎(AIT)的自然病史和发病率。
自1990年以来,对T1D儿童和青少年进行了年度甲状腺疾病筛查。检测了659例患者(54.3%为男孩)的抗甲状腺过氧化物酶抗体(抗-TPO)、抗甲状腺球蛋白抗体(抗-TG)以及促甲状腺激素(TSH)。对126例患者从T1D发病起至5年期间每年随访抗-TPO和抗-TG水平。抗-TPO高于30 U/ml且抗-TG高于20 U/ml被视为阳性,高于100 U/ml则显著升高,提示AIT。若TSH高于4.5 μU/ml和/或甲状腺超声显示甲状腺肿大,则开始左旋甲状腺素治疗。
初次筛查时,15.4%的患者抗-TPO升高,14.4%的患者抗-TG升高。女孩抗体升高的频率高于男孩。62例患者(9.4%,61%为女孩)需要接受左旋甲状腺素治疗。糖尿病10年后AIT的累积发病率(标准误)为0.14(0.02),女性显著更高(0.18(0.03)),尤其是12岁以后。在T1D发病时,126例患者中有21例(16.7%)抗-TPO和抗-TG呈阳性。所有在T1D发病时抗-TPO(n = 17,148 - 5340 U/ml)和抗-TG(n = 11,140 - 2000 U/ml)显著升高的患者在随后5年中仍保持阳性。
为早期发现T1D患儿的自身免疫性甲状腺炎,建议在T1D发病时以及12岁后每年检测抗-TPO和TSH。